A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199
TerminatedNCT03880487
Kalyra Pharmaceuticals, Inc.Analgesia
Start: 2019-03-12End: 2020-04-21Updated: 2021-09-16